Back
Illumina, Inc. 10K Form
Buy
68
ILMN
Illumina, Inc.
Last Price:
$128.99
Seasonality Move:
8.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-11-15 | 10K | ILMN/Illumina, Inc. Annual |
| 2025-10-15 | 10K | ILMN/Illumina, Inc. Annual |
| 2025-09-15 | 10K | ILMN/Illumina, Inc. Annual |
| 2024-05-03 | 10Q | ILMN/Illumina, Inc. Quarterly |
| 2024-02-16 | 10K | ILMN/Illumina, Inc. Annual |
| 2023-11-13 | 10Q | ILMN/Illumina, Inc. Quarterly |
Receive ILMN News And Ratings
See the #1 stock for the next 7 days that we like better than ILMN
ILMN Financial Statistics
Sales & Book Value
| Annual Sales: | $4.4B |
|---|---|
| Cash Flow: | $253M |
| Price / Cash Flow: | 20.31 |
| Annual Sales: | $15.56 |
| Price / Book: | 8.22 |
Profitability
| EPS (TTM): | 4.46350 |
|---|---|
| Net Income (TTM): | $703M |
| Gross Margin: | $2.9B |
| Return on Equity: | 30.55% |
| Return on Assets: | 11.43% |
Illumina, Inc. Earnings Forecast
Key Illumina, Inc. Financial Ratios
-
The Gross Profit Margin over the past 27 years for ILMN is 65.46%.
-
The Selling, General & Administrative Expenses for ILMN have been equal to 24.98% of Gross Profit Margin.
-
The Research & Development expenses have been 26.69% of Revenue.
-
The Net Earning history of ILMN is -27.97% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 14 years.
Illumina, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | ILMN |
| CUSIP: | 452327 |
| Website: | illumina.com |
Debt
| Debt-to-Equity Ratio: | 1.08 |
|---|---|
| Current Ratio: | 1.43 |
| Quick Ratio: | 1.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 25.6 |
ILMN Technical Analysis vs Fundamental Analysis
Buy
68
Illumina, Inc. (ILMN)
is a Buy
Is Illumina, Inc. a Buy or a Sell?
-
Illumina, Inc. stock is rated a BuyThe current Illumina, Inc. [ILMN] share price is $128.03. The Score for ILMN is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.